Expression of functional interieukin-3 receptors on Hodgkin and Reed-Sternberg cells

被引:47
作者
Aldinucci, D
Poletto, D
Gloghini, A
Nanni, P
Degan, M
Perin, T
Ceolin, P
Rossi, FM
Gattei, V
Carbone, A
Pinto, A
机构
[1] Ist Nazl Tumori, IRCCS, Ctr Riferimento Oncol, Clin Expt Hematol Res Unit, I-33081 Aviano, Italy
[2] Ist Nazl Tumori, IRCCS, Ctr Riferimento Oncol, Div Pathol, I-33081 Aviano, Italy
关键词
D O I
10.1016/S0002-9440(10)64878-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The human interleukin-3 receptor (IL-3R) is a heterodimeric complex consisting of an IL-3-specific alpha chain (IL-3Ralpha) and a common beta chain (beta(c)), this latter shared with the receptors for granulocyte-macrophage colony-stimulating factor and IL-5. Despite extensive research on cytokine circuitries regulating proliferation and survival of tumor cells in Hodgkin's disease (HD) the functional expression of IL-3Rs in this pathobiological entity has not yet been investigated. In the present study, we demonstrate that the great majority (>90%) of malignant Hodgkin and Reed-Sternberg cells of classic HD (11.9 of 19 analyzed cases) express IL-3Ralpha by immunostaining of frozen sections and cell suspensions from involved lymph nodes. Accordingly, HD cell lines (L428, KMH2, HDLM2, L1236) expressed the alpha and beta chains of IL-3R both at the mRNA and protein level, with a molecular size of IL-3Ralpha identical (70 kd) to that expressed by human myeloid cells. Exogenous IL-3 promoted the growth of cultured Hodgkin and Reed-Sternberg cells, such effect being potentiated by IL-9 co-stimulation, and was able to partially rescue tumor cells from apoptosis induced by serum deprivation. This data suggests an involvement of IL-3/IL-3R interactions in the cellular growth of HD through paracrine mechanisms.
引用
收藏
页码:585 / 596
页数:12
相关论文
共 68 条
[21]   Pathophysiology of Hodgkin's disease: Functional and molecular aspects [J].
Gruss, HJ ;
Kadin, ME .
BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (03) :417-446
[22]  
GRUSS HJ, 1992, CANCER RES, V52, P1026
[23]  
GRUSS HJ, 1994, BLOOD, V83, P2045
[24]   Hodgkin's disease: A tumor with disturbed immunological pathways [J].
Gruss, HJ ;
Pinto, A ;
Duyster, J ;
Poppema, S ;
Herrmann, F .
IMMUNOLOGY TODAY, 1997, 18 (04) :156-163
[25]   Mechanism of activation of the GM-CSF IL-3, and IL-5 family of receptors [J].
Guthridge, MA ;
Stomski, FC ;
Thomas, D ;
Woodcock, JM ;
Bagley, CJ ;
Berndt, MC ;
Lopez, AF .
STEM CELLS, 1998, 16 (05) :301-313
[26]  
Harris NL, 1999, MODERN PATHOL, V12, P159
[27]  
HARRIS NL, 1994, BLOOD, V84, P1361
[28]   Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes [J].
Ikushima, S ;
Inukai, T ;
Inaba, T ;
Nimer, SD ;
Cleveland, JL ;
Look, AT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2609-2614
[29]  
JUCKER M, 1991, BLOOD, V77, P2413
[30]   Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils [J].
Jundt, F ;
Anagnostopoulos, I ;
Bommert, K ;
Emmerich, F ;
Müller, G ;
Foss, HD ;
Royer, HD ;
Stein, H ;
Dörken, B .
BLOOD, 1999, 94 (06) :2065-2071